Best CT Protocol for Evaluating a Renal Mass

Standard Multiphase CT Protocol Components

A dedicated multiphase CT protocol with intravenous contrast is the optimal imaging approach for evaluating renal masses, including unenhanced, corticomedullary (arterial), and nephrographic phases, as recommended by the American College of Radiology 1, 2
The unenhanced phase is essential as a baseline to assess pre-contrast density, where masses with less than 20 HU or more than 70 HU are typically benign, according to the American College of Radiology 2, 3
The corticomedullary phase (arterial) is obtained 25-70 seconds after contrast injection to evaluate vascularity, as suggested by the American College of Radiology 2, 3
The nephrographic phase, obtained 80-180 seconds after contrast injection, is superior for detecting small renal masses (less than 3 cm), as recommended by the American College of Radiology 2

Thin-slice acquisition improves detection of small lesions and reduces partial volume averaging, as recommended by the American College of Radiology 3, 4
Hounsfield unit (HU) measurements are critical for characterization, where masses measuring 10-20 HU on contrast-enhanced CT are typically benign cysts, according to the American College of Radiology 2, 3
Reconstruction techniques, including maximum intensity projection or 3D volume rendering, are useful when needed, as suggested by the American College of Radiology 3, 4

Dual-energy CT applications improve differentiation between non-enhancing cysts and low-level enhancing tumors, as recommended by the American College of Radiology 2, 3
Dual-energy CT can help differentiate solid tumors from hyperdense cysts when a comprehensive multiphase protocol is not available, according to the American College of Radiology 2, 3
Reduced pseudoenhancement is achieved with virtual monochromatic images, which decrease artifacts that can mimic enhancement in cysts, as suggested by the American College of Radiology 3, 4

MRI with contrast is an excellent alternative when CT is contraindicated, with higher specificity than CT (68.1% vs 27.7%) for characterizing renal lesions, as recommended by the American College of Radiology, although this specific comparison is noted in Praxis Medical Insights 5
Contrast-enhanced ultrasound (CEUS) is useful when iodinated contrast or gadolinium is contraindicated, allowing real-time evaluation of microvasculature, as suggested by the American College of Radiology 2, 3

Initial assessment determines if a mass is indeterminate (20-70 HU on unenhanced CT), as recommended by the American College of Radiology 2, 3
Protocol selection involves choosing a multiphase CT with unenhanced, corticomedullary, and nephrographic phases, as suggested by the American College of Radiology 2, 3
Evaluation assesses the enhancement pattern and HU measurements across all phases, according to the American College of Radiology 2, 3
Consideration of dual-energy CT is recommended when available, particularly for small or indeterminate lesions, as suggested by the American College of Radiology 2, 3
Alternative imaging, such as MRI, should be considered when higher specificity is needed or contrast CT is contraindicated, as recommended by the American College of Radiology 6, 5

According to the American College of Radiology Appropriateness Criteria, a homogeneous renal mass with an attenuation > 70 HU on unenhanced CT is classified as a benign hyperdense cyst and does not require additional imaging work‑up or specialist referral. 7, 8

The American College of Radiology specifies that a benign 70‑HU cyst must demonstrate a homogeneous appearance without internal nodules, septations, or calcifications on non‑contrast CT. 7

The American College of Radiology emphasizes that the ≥ 70 HU threshold is applicable only to non‑contrast CT examinations; attenuation values on contrast‑enhanced phases are not covered by this rule. 7, 8

The American College of Radiology recommends obtaining contrast‑enhanced imaging when any nodules, thick septations, or calcifications are identified within the lesion. 7
The American College of Radiology advises that clinical suspicion based on patient symptoms or risk factors (e.g., hematuria, flank pain, known malignancy) should prompt additional imaging despite an initial 70‑HU measurement. 7

The American College of Radiology states that for a truly homogeneous 70‑HU renal mass on non‑contrast CT, no further imaging is required. 7
Consequently, the American College of Radiology indicates that no urologic referral is necessary for such lesions. 7
The American College of Radiology further notes that routine surveillance imaging is not indicated for confirmed benign hyperdense cysts. 7